Testing thousands of genes in living tumors revealed hidden drivers of aggressive basal-like breast cancer that cell cultures ...

Discover how Dr. Ohmini Krishnamurthy Rajendran, an Indian physician-scientist, is revolutionizing precision oncology. Her ...

By identifying the genes and molecules crucial to resistance in American chestnuts and other species, researchers hope to use ...

By DR. ANIL KUMAR N, Senior Consultant - Medical Oncology, Hemato Oncology & BMT, Cytecare Hospitals, Bangalore , Bizz Impact ...

Microbiome sequencing has a reputation issue. From the outside, it appears to be one of modern biology's most powerful tools: ...

Eliminating unnecessary PCR cleanup and normalization steps helps genomics laboratories reduce consumable waste and ...

Bioinformatics has rapidly evolved from a niche discipline into a global economic and scientific powerhouse. As DNA ...

As a Premier Partner, Gene Solutions presented Asia-led real-world evidence from large-scale NIPT-integrated carrier screening, alongside advances in AI-enabled pregnancy-risk assessment and minimally ...

Tempus AI has agreed to acquire the cancer genomics company Personalis in a deal valued at about $1.5 billion, the companies announced July 20. The acquisition builds on a partnership the two ...

Genomics says it is on track to build out a CLIA-certified laboratory set to open next year, part of the spatial and ...

Two genomics ETFs share the same buzzwords on every screener, but their structures have sent them on wildly different paths ...

Roche's AXELIOS 1 enters next generation DNA sequencing. Can it or rivals unseat Illumina's long-standing market dominance?